Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Expression of collagenases (matrix metalloproteinase-1, 8, 13) and tissue inhibitor of metalloproteinase-1 of retrodiscal tissue in temporomandibular joint disorder patients

  • Gho, Won Gyung (Department of Dentistry, Myongji Hospital) ;
  • Choi, Yuri (Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry) ;
  • Park, Kwang-Ho (Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry) ;
  • Huh, Jong-Ki (Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry)
  • Received : 2017.12.20
  • Accepted : 2018.02.12
  • Published : 2018.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The aim of this study was to reveal how collagenases (matrix metalloproteinase [MMP]-1, 8, 13) and tissue inhibitor of metalloproteinase 1 (TIMP-1) are expressed in immunohistochemistry of retrodiscal tissue in temporomandibular joint disorder patients. Materials and Methods: This study was conducted on 39 patients who underwent discoplasty or discectomy. Immunohistochemical staining was undertaken and expression levels of MMP-1, 8, 13, and TIMP-1 were evaluated. The status of internal derangement of disc, osteoarthritis, and joint effusion were analyzed using magnetic resonance imaging (MRI). Disc status observed during operation was also categorized. Results: The more severe disc derangement was observed on MRI, the more increased expression of MMPs and TIMP-1 appeared. Regarding MMP-13 expression, 86.7% of late-stage disc displacement patients showed grade II or III. Expression level of MMPs or TIMP was not statistically significant associated with joint effusion level. In perforation and/or adhesion groups, all patients showed grade II or III expression of MMP-13. Once perforation occurred, MMP-13 showed increased expression with statistical significance. Conclusion: MMP-1 and MMP-13 expression seem to be related to progression of osteoarthritis whereas MMP-8 does not seem to have a specific role with regard to temporomandibular joint disorders. TIMP-1 is considered to be partly related to internal derangement rather than osteoarthritis, but it is not significant.

Keywords

References

  1. Ishibashi H, Takenoshita Y, Ishibashi K, Oka M. Expression of extracellular matrix in human mandibular condyle. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:402-14. https://doi.org/10.1016/S1079-2104(96)80015-1
  2. Kapila S, Lee C, Richards DW. Characterization and identification of proteinases and proteinase inhibitors synthesized by temporomandibular joint disc cells. J Dent Res 1995;74:1328-36. https://doi.org/10.1177/00220345950740061301
  3. Vaatainen U, Lohmander LS, Thonar E, Hongisto T, Agren U, Ronkko S, et al. Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella. Osteoarthritis Cartilage 1998;6:115-24. https://doi.org/10.1053/joca.1997.0101
  4. Kubota E, Kubota T, Matsumoto J, Shibata T, Murakami KI. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 1998;56:192-8. https://doi.org/10.1016/S0278-2391(98)90868-0
  5. Imai K, Ohta S, Matsumoto T, Fujimoto N, Sato H, Seiki M, et al. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol 1997;151:245-56.
  6. Imai S, Konttinen YT, Jumppanen M, Lindy O, Ceponis A, Kemppinen P, et al. High levels of expression of collagenase-3 (MMP-13) in pathological conditions associated with a foreign-body reaction. J Bone Joint Surg Br 1998;80:701-10. https://doi.org/10.1302/0301-620X.80B4.7952
  7. Kubota E, Imamura H, Kubota T, Shibata T, Murakami K. Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 1997;55:20-7; discussion 27-8. https://doi.org/10.1016/S0278-2391(97)90438-9
  8. Tiilikainen P, Pirttiniemi P, Kainulainen T, Pernu H, Raustia A. MMP-3 and -8 expression is found in the condylar surface of temporomandibular joints with internal derangement. J Oral Pathol Med 2005;34:39-45. https://doi.org/10.1111/j.1600-0714.2004.00262.x
  9. Huh JK, Kim HG, Ko JY. Magnetic resonance imaging of temporomandibular joint synovial fluid collection and disk morphology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:665-71. https://doi.org/10.1067/moe.2003.159
  10. McDonnell S, Morgan M, Lynch C. Role of matrix metalloproteinases in normal and disease processes. Biochem Soc Trans 1999;27:734-40. https://doi.org/10.1042/bst0270734
  11. Mizui T, Ishimaru J, Miyamoto K, Kurita K. Matrix metalloproteinase-2 in synovial lavage fluid of patients with disorders of the temporomandibular joint. Br J Oral Maxillofac Surg 2001;39:310-4. https://doi.org/10.1054/bjom.2001.0634
  12. Dioszegi M, Cannon P, Van Wart HE. Vertebrate collagenases. Methods Enzymol 1995;248:413-31.
  13. Jeffrey JJ. Interstitial collagenases. In: Parks WC, Mecham RP, eds. Matrix metalloproteinases. San Diego: Academic Press; 1998.
  14. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.
  15. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 1996;97:2011-9. https://doi.org/10.1172/JCI118636
  16. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8. https://doi.org/10.1172/JCI118475
  17. Hasty KA, Jeffrey JJ, Hibbs MS, Welgus HG. The collagen substrate specificity of human neutrophil collagenase. J Biol Chem 1987;262:10048-52.
  18. Welgus HG, Jeffrey JJ, Eisen AZ. The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem 1981;256:9511-5.
  19. Gepstein A, Shapiro S, Arbel G, Lahat N, Livne E. Expression of matrix metalloproteinases in articular cartilage of temporomandibular and knee joints of mice during growth, maturation, and aging. Arthritis Rheum 2002;46:3240-50. https://doi.org/10.1002/art.10690
  20. Gepstein A, Arbel G, Blumenfeld I, Peled M, Livne E. Association of metalloproteinases, tissue inhibitors of matrix metalloproteinases, and proteoglycans with development, aging, and osteoarthritis processes in mouse temporomandibular joint. Histochem Cell Biol 2003;120:23-32. https://doi.org/10.1007/s00418-003-0544-1
  21. Huh JK, Park KK, Choi MA, Kim HG. Expression of matrix metalloproteinase-1 and -2 mRNA in retrodiscal tissue of the temporomandibular joint. J Korean Assoc Oral Maxillofac Surg 2003;29:212-8.
  22. Ishimaru JI, Oguma Y, Goss AN. Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and lavage synovial fluid of patients with temporomandibular joint disorders. Br J Oral Maxillofac Surg 2000;38:354-9. https://doi.org/10.1054/bjom.2000.0306
  23. Leonardi R, Loreto C, Barbato E, Caltabiano R, Lombardo C, Musumeci G, et al. MMP-13 (collagenase 3) localization in human temporomandibular joint discs with internal derangement. Acta Histochem 2008;110:314-8. https://doi.org/10.1016/j.acthis.2007.11.010
  24. Marchetti C, Cornaglia I, Casasco A, Bernasconi G, Baciliero U, Stetler-Stevenson WG. Immunolocalization of gelatinase-A (matrix metalloproteinase-2) in damaged human temporomandibular joint discs. Arch Oral Biol 1999;44:297-304. https://doi.org/10.1016/S0003-9969(98)00107-1
  25. Gomis-Ruth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 1997;389:77-81. https://doi.org/10.1038/37995
  26. Naito K, Takahashi M, Kushida K, Suzuki M, Ohishi T, Miura M, et al. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis. Rheumatology (Oxford) 1999;38:510-5. https://doi.org/10.1093/rheumatology/38.6.510
  27. Wang YL, Li XJ, Qin RF, Lei DL, Liu YP, Wu GY, et al. Matrix metalloproteinase and its inhibitor in temporomandibular joint osteoarthrosis after indirect trauma in young goats. Br J Oral Maxillofac Surg 2008;46:192-7. https://doi.org/10.1016/j.bjoms.2007.10.007
  28. Sawatsubashi M, Mizokami H, Tokunaga O, Shin T. Expression of MMP-1, TIMP-1, and type I collagen in laryngeal carcinoma. Mod Pathol 1998;11:878-85.

Cited by

  1. Herbal Composition LI73014F2 Alleviates Articular Cartilage Damage and Inflammatory Response in Monosodium Iodoacetate-Induced Osteoarthritis in Rats vol.25, pp.22, 2018, https://doi.org/10.3390/molecules25225467
  2. Overexpression of MMPs, cytokines, and RANKL/OPG in temporomandibular joint osteoarthritis and their association with joint pain, mouth opening, and bone degeneration: A preliminary report vol.27, pp.4, 2018, https://doi.org/10.1111/odi.13623
  3. A comprehensive review on biomarkers associated with painful temporomandibular disorders vol.13, pp.1, 2018, https://doi.org/10.1038/s41368-021-00129-1